Wells Fargo & Company Agios Pharmaceuticals, Inc. Transaction History

Wells Fargo & Company

$429 Billion
Q1 2025

A detailed history of Wells Fargo & Company transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 68,137 shares of AGIO stock, worth $2.46 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

68,137

Previous 34,808 95.75%

Holding current value

$2.46 Million

Previous $1.14 Million 74.63%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$29.3 - $35.9 $976,539 - $1.2 Million	33,329 Added 95.75%	68,137 $2 Million
Q4 2024 Feb 12, 2025	SELL	$32.86 - $61.64 $124,868 - $234,232	-3,800 Reduced 9.84%	34,808 $1.14 Million
Q3 2024 Nov 13, 2024	SELL	$41.19 - $49.72 $56,471 - $68,166	-1,371 Reduced 3.43%	38,608 $1.72 Million
Q2 2024 Aug 13, 2024	SELL	$27.55 - $48.83 $723,628 - $1.28 Million	-26,266 Reduced 39.65%	39,979 $1.72 Million
Q1 2024 May 10, 2024	SELL	$21.32 - $34.81 $1.32 Million - $2.16 Million	-62,138 Reduced 48.4%	66,245 $1.94 Million
Q4 2023 Feb 09, 2024	SELL	$19.97 - $24.53 $37,503 - $46,067	-1,878 Reduced 1.44%	128,383 $2.86 Million
Q3 2023 Nov 13, 2023	SELL	$24.36 - $28.18 $290,127 - $335,623	-11,910 Reduced 8.38%	130,261 $3.22 Million
Q2 2023 Aug 15, 2023	SELL	$21.38 - $29.19 $169,906 - $231,972	-7,947 Reduced 5.29%	142,171 $4.03 Million
Q1 2023 May 12, 2023	BUY	$21.74 - $30.93 $3.21 Million - $4.57 Million	147,628 Added 5928.84%	150,118 $3.45 Million
Q4 2022 Feb 13, 2023	SELL	$24.81 - $31.52 $47,957 - $60,928	-1,933 Reduced 43.7%	2,490 $69,000
Q3 2022 Nov 14, 2022	SELL	$19.51 - $34.14 $10,476 - $18,333	-537 Reduced 10.83%	4,423 $124,000
Q2 2022 Aug 12, 2022	SELL	$17.06 - $31.42 $520,381 - $958,404	-30,503 Reduced 86.01%	4,960 $111,000
Q1 2022 May 16, 2022	SELL	$26.68 - $34.81 $467,060 - $609,383	-17,506 Reduced 33.05%	35,463 $1.03 Million
Q4 2021 Feb 14, 2022	SELL	$29.58 - $49.78 $630,349 - $1.06 Million	-21,310 Reduced 28.69%	52,969 $1.74 Million
Q3 2021 Nov 15, 2021	BUY	$41.92 - $58.18 $224,733 - $311,902	5,361 Added 7.78%	74,279 $3.43 Million
Q2 2021 Aug 16, 2021	SELL	$52.06 - $61.27 $2.97 Million - $3.49 Million	-56,971 Reduced 45.25%	68,918 $3.8 Million
Q1 2021 May 13, 2021	SELL	$44.23 - $57.5 $2.76 Million - $3.59 Million	-62,440 Reduced 33.15%	125,889 $6.5 Million
Q4 2020 Feb 09, 2021	BUY	$33.21 - $46.54 $1.4 Million - $1.97 Million	42,273 Added 28.94%	188,329 $8.16 Million
Q3 2020 Nov 05, 2020	SELL	$33.87 - $55.93 $686,781 - $1.13 Million	-20,277 Reduced 12.19%	146,056 $5.11 Million
Q2 2020 Aug 13, 2020	BUY	$34.45 - $53.48 $513,098 - $796,531	14,894 Added 9.83%	166,333 $8.89 Million
Q1 2020 May 14, 2020	BUY	$31.52 - $53.81 $4.77 Million - $8.15 Million	151,439 New	151,439 $5.37 Million

Others Institutions Holding AGIO

# of Institutions

237

Shares Held

60.1M

Call Options Held

323K

Put Options Held

367K

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.98B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Agios Pharmaceuticals, Inc. Transaction History